Intravenous Immunoglobulins Market Size to surpass 6.2% CAGR up to 2025

The global intravenous immunoglobulin market is likely to witness considerable growth driven by recent molecular advancements. According to a report published by Fortune Business Insights, titled “Intravenous Immunoglobulin Market Size, Share & Industry Analysis By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Regional Forecast, 2018 – 2025,” the was valued at USD 9,787.6 Million in 2017 and is projected to reach USD 15,789.1 Million by 2025 exhibiting a CAGR of 6.2% in the forecast period (2018-2025).

Leave a Reply

Your email address will not be published. Required fields are marked *